Libero Pharma
PrivateLast Round
VC Round
Jun 2, 2026
Total Funding Raised
$3.16M
Company Overview
Libero Pharma operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a VC Round in June 2026.
Libero Pharma is a biotechnology company that develops transdermal naltrexone patch delivery systems for the management of opioid use disorder, alcohol use disorder, and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Libero Pharma Comparables
Compare Libero Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medherant Limited | 82% | |
| Alkermes plc | 62% | |
| Corium Innovations | 61% |
For institutional investors. Book with your work email.
Libero Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 2, 2026 | ||||
| VC Round | Nov 15, 2022 | ||||
| Grant | Sep 20, 2022 | ||||
| VC Round | May 10, 2021 | ||||
| VC Round | Apr 29, 2019 |
For institutional investors. Book with your work email.
Libero Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The TRICAPITAL Syndicate | VC Round |
| Highland Venture Capital | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2019
$320K raised from Highland Venture Capital and others.
For institutional investors. Book with your work email.
Libero Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Libero Pharma's valuation, stock price, and market status.
Is Libero Pharma a public or private company?
Libero Pharma is a private company.
What is the current stock price of Libero Pharma?
Libero Pharma is a private company, so its shares have no public market price. Caplight tracks Libero Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Libero Pharma worth (valuation)?
Valuation information for Libero Pharma is not publicly available.
Can I buy Libero Pharma stock?
Libero Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Libero Pharma's last funding round?
Libero Pharma's most recent funding round was VC Round on June 2, 2026.
Who are the main investors in Libero Pharma?
Key investors in Libero Pharma include The TRICAPITAL Syndicate, Highland Venture Capital, Scottish Investment Bank (Scottish Enterprise), National Institute on Drug Abuse.
Will Libero Pharma IPO soon?
No public IPO plans have been announced for Libero Pharma.
How can I track Libero Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Libero Pharma's shares on secondary markets.